Snapshot from Jul 31, 2026 at 07:00 UTC. For live data and tracking: View Live
Domestic policy change

Germany ends routine COVID-19 shots for under 75

Analysis based on 6 articles · First reported Jul 13, 2026 · Last updated Jul 15, 2026

Sentiment
10
Attention
3
Articles
6
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The policy change may reduce demand for COVID-19 vaccines in Germany, potentially impacting revenues for vaccine manufacturers like BioNTech and Pfizer. However, the shift is gradual and reflects existing low uptake, so the immediate market impact is limited.

pharmaceuticals healthcare

Germany's India — Standing Committee on Finance (STIKO) updated its COVID-19 vaccination recommendations on July 9, 2026, advising that most people under 75, including healthy pregnant women, no longer need routine vaccination. The decision is based on high levels of hybrid immunity in the population (over 95% of adults have antibodies), declining hospitalizations and deaths, and the virus now behaving like a seasonal respiratory virus. Routine vaccination is now recommended only for those aged 75 and older, long-term care residents, immunocompromised persons, and pregnant women with underlying conditions. The change aligns with similar moves in Switzerland, the UK, and the US. The policy has generated mixed reactions from health experts, with some welcoming it as evidence-based and others criticizing it as overdue. Vaccine uptake in Germany has declined, with only 20.9% of adults 60+ receiving a booster in the 2024-25 season. The update follows a broader international trend toward targeting vaccination to the most vulnerable.

100 India — Standing Committee on Finance updated vaccination recommendations
90 India — Standing Committee on Finance ended routine recommendations
50 United States — Centers for Disease Control and Prevention rolled back vaccine recommendations
40 United States shifted toward risk-based approach
30 Switzerland stopped recommending vaccines
30 United Kingdom narrowed vaccination programme
20 Karl Lauterbach admitted adverse events prevalent
10 Stefan Homburg alleged political alignment
10 Torsten Engelbrecht criticized RKI for manipulating mortality statistics Germany — Robert Koch Institute
cnt
Germany's public health authority STIKO issued the updated vaccination guidance, reflecting the country's assessment of the pandemic's current phase.
Importance 100.0 Sentiment 10.0
govactor
STIKO is the independent advisory committee that made the recommendation to end routine COVID-19 vaccination for most under 75.
Importance 100.0 Sentiment 10.0
govactor
RKI provides scientific support to STIKO and has faced criticism over alleged manipulation of mortality statistics, though the new guidance is seen as aligning policy with evidence.
Importance 60.0 Sentiment -10.0
stock
BioNTech's COVID-19 vaccine (with Pfizer) may see reduced demand in Germany due to the narrowed recommendations, though uptake was already low.
Importance 40.0 Sentiment -20.0
stock
Pfizer's COVID-19 vaccine (with BioNTech) may see reduced demand in Germany; the company has faced scrutiny over adverse event data.
Importance 40.0 Sentiment -20.0
cnt
The US has shifted toward a risk-based approach; Health Secretary Robert F. Kennedy Jr. has advocated stopping recommendations for children.
Importance 30.0 Sentiment 0.0
govactor
The US CDC has also revised its guidance toward a risk-based approach, but a federal court blocked its January 2026 update; an appeal is ongoing.
Importance 30.0 Sentiment 0.0
cnt
The UK previously narrowed its COVID-19 vaccination programme to older adults, care home residents, and immunocompromised individuals.
Importance 20.0 Sentiment 0.0
govactor
EMA oversees vaccine safety in the EU and received confidential documents from BioNTech regarding adverse events, but the policy change is a national decision.
Importance 20.0 Sentiment 0.0
ngo
WHO continues to maintain that benefits of COVID-19 vaccination outweigh risks for recommended groups, but is not directly involved in Germany's policy change.
Importance 20.0 Sentiment 0.0
cnt
Switzerland stopped recommending COVID-19 vaccines for spring and summer, even for high-risk groups, citing high immunity.
Importance 20.0 Sentiment 0.0
per
Former German Health Minister Lauterbach admitted vaccine adverse events are prevalent and called for better support for injured individuals.
Importance 20.0 Sentiment -10.0
per
US Health Secretary Kennedy has advocated for the CDC to stop recommending COVID-19 shots for children, citing lack of evidence of benefit.
Importance 20.0 Sentiment -10.0
stock
AstraZeneca's vaccine was previously suspended for under 60s in Germany in 2021 due to blood clot concerns; not directly affected by current policy.
Importance 10.0 Sentiment 0.0
per
Health researcher Walach described the revised guidance as an indirect acknowledgment that repeated vaccinations are unnecessary for most healthy adults.
Importance 10.0 Sentiment 0.0
+ 4 more entities View on Dashboard
Germany strained ally United States Germany remains a key defense partner of the United States, deepening its reliance on American military technology, but
Germany allies United Kingdom Germany views the United Kingdom as a key European security ally and major trade partner, cooperating closely within NAT
Pfizer related United States
United States allies United Kingdom The United States considers the United Kingdom a vital defense ally and significant economic partner, relying on its str
+ 2 more relationships View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.